Compile Data Set for Download or QSAR

Found 90 hits Enz. Inhib. hit(s) with all data for entry = 8908   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Protein P (HBV)	BDBM427204 (US10544141, Compound 264) Show SMILES Clc1cccc(NC(=O)N2CCc3[nH]nc(C4CCCC4)c3C2)c1 Show InChI InChI=1S/C18H21ClN4O/c19-13-6-3-7-14(10-13)20-18(24)23-9-8-16-15(11-23)17(22-21-16)12-4-1-2-5-12/h3,6-7,10,12H,1-2,4-5,8-9,11H2,(H,20,24)(H,21,22)	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427223 (US10544141, Compound 441) Show SMILES CC1(CC1)c1n[nH]c2CCN(Cc12)C(=O)Nc1cccc(Cl)c1 Show InChI InChI=1S/C17H19ClN4O/c1-17(6-7-17)15-13-10-22(8-5-14(13)20-21-15)16(23)19-12-4-2-3-11(18)9-12/h2-4,9H,5-8,10H2,1H3,(H,19,23)(H,20,21)	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	300	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427240 (US10544141, Compound 267) Show SMILES CC(C)c1n[nH]c2CCN(Cc12)C(=O)Nc1cccc(Cl)c1 Show InChI InChI=1S/C16H19ClN4O/c1-10(2)15-13-9-21(7-6-14(13)19-20-15)16(22)18-12-5-3-4-11(17)8-12/h3-5,8,10H,6-7,9H2,1-2H3,(H,18,22)(H,19,20)	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	300	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427466 (US10544141, Compound 455) Show SMILES Clc1cccc(NC(=O)N2CCc3[nH]nc(N4CCCC4)c3C2)c1 Show InChI InChI=1S/C17H20ClN5O/c18-12-4-3-5-13(10-12)19-17(24)23-9-6-15-14(11-23)16(21-20-15)22-7-1-2-8-22/h3-5,10H,1-2,6-9,11H2,(H,19,24)(H,20,21)	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	300	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427484 (US10544141, Compound 274) Show SMILES Clc1cccc(NC(=O)N2CCc3[nH]nc(c3C2)C2=CCOCC2)c1 |t:20| Show InChI InChI=1S/C18H19ClN4O2/c19-13-2-1-3-14(10-13)20-18(24)23-7-4-16-15(11-23)17(22-21-16)12-5-8-25-9-6-12/h1-3,5,10H,4,6-9,11H2,(H,20,24)(H,21,22)	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	300	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427485 (US10544141, Compound 515) Show SMILES CC(C)(C)c1n[nH]c2CCN(Cc12)C(=O)Nc1cccc(Cl)c1 Show InChI InChI=1S/C17H21ClN4O/c1-17(2,3)15-13-10-22(8-7-14(13)20-21-15)16(23)19-12-6-4-5-11(18)9-12/h4-6,9H,7-8,10H2,1-3H3,(H,19,23)(H,20,21)	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	300	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427486 (US10544141, Compound 275) Show SMILES Clc1cccc(NC(=O)N2CCc3[nH]nc(C4CCOCC4)c3C2)c1 Show InChI InChI=1S/C18H21ClN4O2/c19-13-2-1-3-14(10-13)20-18(24)23-7-4-16-15(11-23)17(22-21-16)12-5-8-25-9-6-12/h1-3,10,12H,4-9,11H2,(H,20,24)(H,21,22)	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	300	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427487 (US10544141, Compound 546) Show SMILES Clc1cccc(NC(=O)N2CCc3[nH]nc(c3C2)C23CC2CCC3)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427488 (US10544141, Compound 336) Show SMILES CC(=C)c1n[nH]c2CCN(Cc12)C(=O)Nc1cccc(Cl)c1 Show InChI InChI=1S/C16H17ClN4O/c1-10(2)15-13-9-21(7-6-14(13)19-20-15)16(22)18-12-5-3-4-11(17)8-12/h3-5,8H,1,6-7,9H2,2H3,(H,18,22)(H,19,20)	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427489 (US10544141, Compound 547) Show SMILES CC(=C)c1n[nH]c2CCN(Cc12)C(=O)Nc1ccnc(Cl)c1F Show InChI InChI=1S/C15H15ClFN5O/c1-8(2)13-9-7-22(6-4-10(9)20-21-13)15(23)19-11-3-5-18-14(16)12(11)17/h3,5H,1,4,6-7H2,2H3,(H,20,21)(H,18,19,23)	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	300	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427490 (US10544141, Compound 337) Show SMILES Clc1cccc(NC(=O)N2CCc3[nH]nc(c3C2)C2=CCCCC2)c1 |t:20| Show InChI InChI=1S/C19H21ClN4O/c20-14-7-4-8-15(11-14)21-19(25)24-10-9-17-16(12-24)18(23-22-17)13-5-2-1-3-6-13/h4-5,7-8,11H,1-3,6,9-10,12H2,(H,21,25)(H,22,23)	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427491 (US10544141, Compound 548) Show SMILES CC(=C)c1n[nH]c2CCN(Cc12)C(=O)Nc1cccc(Br)c1F Show InChI InChI=1S/C16H16BrFN4O/c1-9(2)15-10-8-22(7-6-12(10)20-21-15)16(23)19-13-5-3-4-11(17)14(13)18/h3-5H,1,6-8H2,2H3,(H,19,23)(H,20,21)	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427492 (US10544141, Compound 338) Show SMILES Clc1cccc(NC(=O)N2CCc3[nH]nc(C4=CCCC4)c3C2)c1 |t:16| Show InChI InChI=1S/C18H19ClN4O/c19-13-6-3-7-14(10-13)20-18(24)23-9-8-16-15(11-23)17(22-21-16)12-4-1-2-5-12/h3-4,6-7,10H,1-2,5,8-9,11H2,(H,20,24)(H,21,22)	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427493 (US10544141, Compound 549) Show SMILES CC(=C)c1n[nH]c2CCN(Cc12)C(=O)Nc1cccc(C)c1 Show InChI InChI=1S/C17H20N4O/c1-11(2)16-14-10-21(8-7-15(14)19-20-16)17(22)18-13-6-4-5-12(3)9-13/h4-6,9H,1,7-8,10H2,2-3H3,(H,18,22)(H,19,20)	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	300	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427494 (US10544141, Compound 861) Show SMILES Clc1cccc(NC(=O)N2CCc3[nH]nc(C4CCCO4)c3C2)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427495 (US10544141, Compound 554) Show SMILES Clc1cccc(NC(=O)N2CCc3[nH]nc(C4CCC4)c3C2)c1 Show InChI InChI=1S/C17H19ClN4O/c18-12-5-2-6-13(9-12)19-17(23)22-8-7-15-14(10-22)16(21-20-15)11-3-1-4-11/h2,5-6,9,11H,1,3-4,7-8,10H2,(H,19,23)(H,20,21)	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427496 (US10544141, Compound 761) Show SMILES CC1Cc2[nH]nc(C3CCC3)c2CN1C(=O)Nc1cccc(C#N)c1F Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	300	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427496 (US10544141, Compound 761) Show SMILES CC1Cc2[nH]nc(C3CCC3)c2CN1C(=O)Nc1cccc(C#N)c1F Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	300	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427497 (US10544141, Compound 927) Show SMILES CC1Cc2[nH]nc(C3CCCC3)c2CN1C(=O)Nc1cccc(Br)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427497 (US10544141, Compound 927) Show SMILES CC1Cc2[nH]nc(C3CCCC3)c2CN1C(=O)Nc1cccc(Br)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427498 (US10544141, Compound 928) Show SMILES CC1Cc2[nH]nc(C3CCCC3)c2CN1C(=O)Nc1ccc(F)c(Br)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427498 (US10544141, Compound 928) Show SMILES CC1Cc2[nH]nc(C3CCCC3)c2CN1C(=O)Nc1ccc(F)c(Br)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427499 (US10544141, Compound 929) Show SMILES CC1Cc2[nH]nc(C3CCCC3)c2CN1C(=O)Nc1ccnc(Br)c1F Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427499 (US10544141, Compound 929) Show SMILES CC1Cc2[nH]nc(C3CCCC3)c2CN1C(=O)Nc1ccnc(Br)c1F Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427500 (US10544141, Compound 930) Show SMILES CC1Cc2[nH]nc(C3CCCC3)c2CN1C(=O)Nc1ccc(F)c(c1)C#N Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427500 (US10544141, Compound 930) Show SMILES CC1Cc2[nH]nc(C3CCCC3)c2CN1C(=O)Nc1ccc(F)c(c1)C#N Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427501 (US10544141, Compound 931) Show SMILES CC1Cc2[nH]nc(C3CCCC3)c2CN1C(=O)Nc1ccc(F)c(C)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427501 (US10544141, Compound 931) Show SMILES CC1Cc2[nH]nc(C3CCCC3)c2CN1C(=O)Nc1ccc(F)c(C)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427502 (US10544141, Compound 932) Show SMILES CC1Cc2[nH]nc(C3CCCC3)c2CN1C(=O)Nc1ccc(F)c(Cl)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427502 (US10544141, Compound 932) Show SMILES CC1Cc2[nH]nc(C3CCCC3)c2CN1C(=O)Nc1ccc(F)c(Cl)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427503 (US10544141, Compound 933) Show SMILES CC1Cc2[nH]nc(C3CCCC3)c2CN1C(=O)Nc1cccc(C)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427503 (US10544141, Compound 933) Show SMILES CC1Cc2[nH]nc(C3CCCC3)c2CN1C(=O)Nc1cccc(C)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427504 (US10544141, Compound 934) Show SMILES CC1Cc2[nH]nc(C3CCCC3)c2CN1C(=O)Nc1cccc(Cl)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427504 (US10544141, Compound 934) Show SMILES CC1Cc2[nH]nc(C3CCCC3)c2CN1C(=O)Nc1cccc(Cl)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427505 (US10544141, Compound 964) Show SMILES CC1Cc2[nH]nc(C3CCCO3)c2CN1C(=O)Nc1cccc(Cl)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427506 (US10544141, Compound 965) Show SMILES CC1Cc2[nH]nc(C3CCCO3)c2CN1C(=O)Nc1ccc(F)c(Cl)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427506 (US10544141, Compound 965) Show SMILES CC1Cc2[nH]nc(C3CCCO3)c2CN1C(=O)Nc1ccc(F)c(Cl)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427507 (US10544141, Compound 966) Show SMILES CC1Cc2[nH]nc(C3CCCO3)c2CN1C(=O)Nc1cccc(Br)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427508 (US10544141, Compound 967) Show SMILES CC1Cc2[nH]nc(C3CCCO3)c2CN1C(=O)Nc1ccc(F)c(Br)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427508 (US10544141, Compound 967) Show SMILES CC1Cc2[nH]nc(C3CCCO3)c2CN1C(=O)Nc1ccc(F)c(Br)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	300	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427509 (US10544141, Compound 968) Show SMILES CC1Cc2[nH]nc(C3CCCO3)c2CN1C(=O)Nc1ccnc(Br)c1F Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	750	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427510 (US10544141, Compound 969) Show SMILES CC1Cc2[nH]nc(C3CCCO3)c2CN1C(=O)Nc1ccc(F)c(c1)C#N Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	300	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427510 (US10544141, Compound 969) Show SMILES CC1Cc2[nH]nc(C3CCCO3)c2CN1C(=O)Nc1ccc(F)c(c1)C#N Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	300	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427511 (US10544141, Compound 970) Show SMILES CC1Cc2[nH]nc(C3CCCO3)c2CN1C(=O)Nc1cccc(C)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	300	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427512 (US10544141, Compound 971) Show SMILES CC1Cc2[nH]nc(C3CCCO3)c2CN1C(=O)Nc1ccc(F)c(C)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	55	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427512 (US10544141, Compound 971) Show SMILES CC1Cc2[nH]nc(C3CCCO3)c2CN1C(=O)Nc1ccc(F)c(C)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	300	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427513 (US10544141, Compound 238) Show SMILES CC(C)(O)c1n[nH]c2CCN(Cc12)C(=O)Nc1cccc(Cl)c1 Show InChI InChI=1S/C16H19ClN4O2/c1-16(2,23)14-12-9-21(7-6-13(12)19-20-14)15(22)18-11-5-3-4-10(17)8-11/h3-5,8,23H,6-7,9H2,1-2H3,(H,18,22)(H,19,20)	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427514 (US10544141, Compound 260) Show SMILES Clc1cccc(NC(=O)N2CCc3[nH]nc(Br)c3C2)c1 Show InChI InChI=1S/C13H12BrClN4O/c14-12-10-7-19(5-4-11(10)17-18-12)13(20)16-9-3-1-2-8(15)6-9/h1-3,6H,4-5,7H2,(H,16,20)(H,17,18)	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427515 (US10544141, Compound 241) Show SMILES Oc1n[nH]c2CCN(Cc12)C(=O)Nc1cccc(Cl)c1 Show InChI InChI=1S/C13H13ClN4O2/c14-8-2-1-3-9(6-8)15-13(20)18-5-4-11-10(7-18)12(19)17-16-11/h1-3,6H,4-5,7H2,(H,15,20)(H2,16,17,19)	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair
Protein P (HBV)	BDBM427516 (US10544141, Compound 388) Show SMILES CC(CO)c1n[nH]c2CCN(Cc12)C(=O)Nc1cccc(Cl)c1 Show InChI	UniProtKB/SwissProt GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	>1.00E+4	n/a	n/a	n/a	n/a
NOVIRA THERAPEUTICS, INC. US Patent					Assay Description HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...				US Patent US10544141 (2020) BindingDB Entry DOI: 10.7270/Q2V69MZV
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 90 total )  |  Next  |  Last  >>

Jump to: